By Lorraine Johnson

LYMEPOLICYWONK: “Super responders” are key to personalized Lyme disease treatment

I’m excited to report that the first study using information from MyLymeData has just been published in the medical journal Healthcare.

Using patient-reported outcome data from 3,900 people enrolled in MyLymeData, we looked at how individual patients vary in their response to treatment. Finding out who responds well to which treatments—and then learning more about those people—is an important step towards developing personalized Lyme disease treatment.

Treatment studies of patients with late/chronic Lyme disease usually take an average of how people have responded to treatment. But guess what? The average Lyme patient isn’t average! Some people improve a lot with treatment, some improve a little bit, and some people don’t improve at all. A few may even get worse.

Super responders

However, if we can identify the “super responders”—the ones who did particularly well—and take a closer look at them, we may be able to learn things that can help other patients in a similar situation. This can help drive the development of personalized Lyme disease treatment.

For lots of diseases, such as tuberculosis, pulmonary disease, and cancer, scientists are now identifying high treatment responders, but our study is the first to use this approach in Lyme disease.

The reason it hasn’t been done before in Lyme disease is because identifying how different groups of patients respond to treatment requires large samples. The largest trial funded by the National Institute of Health for patients with chronic Lyme disease enrolled just 129 people—way too small a group to look at individual treatment variation.

So instead, they lumped all of the treatment responses together—the good, the bad and the ugly—and said how patients responded “on average.” On average, there wasn’t much improvement from treatment.

But treatment averages don’t tell the whole story. A famous mathematician, Des MacHale, explains it this way: The average person has one testicle and one breast. And we all know how ridiculous that is. You can’t average a male and a female like that and get any meaningful information.

It’s the same thing when you measure patient treatment response in Lyme disease. If one person gets better and the other gets worse after treatment, you can say that on average, treatment did nothing. However, for the patient who got better, it made a world of difference. Yet, when we use an average to calculate treatment response, the favorable response of one patient is cancelled out by the negative response of another.

A better approach looks at variations in how different patients respond. Most Lyme disease patients already know this. Some patients get better, others get worse, and some don’t change with treatment. Treatment response variation is lost when individual responses are averaged.

In our study, we included close to 4,000 patients, a large enough sample to look at variations in treatment response. Here’s what we found. Most patients (52%) responded positively to antibiotic treatment and some—roughly a third—responded very well to treatment. These patients said that they felt moderately to a very great deal better after taking antibiotics. Very few said that they felt worse after taking antibiotics (only 12%).

If I were a patient with chronic Lyme disease—which I was by the way–I would want to know that roughly a third of those in the sample were “high treatment responders”—meaning that they reported that after taking antibiotics their symptoms improved moderately to a very great deal. This is the type of information that patients want to know and that is why we conducted this study.

This is the first of many studies to be published using the data from MyLymeData.  So stay tuned! And if you are not enrolled in MyLymeData—I encourage you to stop what you are doing and sign up now. It is only by having patients pool their data that we will make progress in this disease.

Here is a short video I recorded explaining more about the study’s results.

Click here to read the full study.

Click here to enroll in MyLymeData.

Lorraine Johnson, JD, MBA, is the Chief Executive Officer of You can contact her at On Twitter, follow her @lymepolicywonk. If you have not signed up for our patient-centered big data project, MyLymeData, please register now.



If you haven’t enrolled in this Bigdata research, please do.

The more people who do this, the more information we will have to look at.

Since the largest NIH study was done in 2008, EIGHT YEARS AGO, you’d think researchers & doctors would be a bit open-minded.  Can you imagine basing cancer or AIDS treatments on EIGHT YEAR OLD STUDIES?  Another, done in 2003 (15 years ago) only looked at 28 days of IV antibiotic compared to placebo in 55 patients, hardly a representative sample, and what’s 28 days of IV abx going to do with a persistent pathogen typically coupled with other pathogens making cases extremely complex?

No, The Cabal has run the research in a biased and skewed manner for over 40 years.  Time for a change.

Interestingly, an IDSA founder disagreed with their stance and used high powered antibiotics quite successfully: 51 difficult cases are represented.



‘RHONY’ Star Ramona Singer Opens Up About Sister’s Devastating Battle With Lyme Disease


Syed Kazmi


It was three decades ago when Ramona Singer first heard about Lyme disease, puzzled about what the mysterious illness was after a partner mentioned the term. Little did the Real Housewives of New York City star realize how much the disease would impact her in years to come, which would see her witness several close friends battle the disease and go on a “rampage” to find the best doctors after learning her own sister had the potentially fatal, tick-borne illness.

“I was involved with a man who’s a doctor and he volunteered at the first Lyme disease clinic at Lenox Hill maybe 30 years ago and when he first told me I said, ‘What do you mean, Lyme disease!?” Singer recalls to ET. “Then his sister started complaining about not feeling well and being fatigued — he thought she was just being a hypochondriac, then found out she had Lyme!”

Singer was later distraught to find out her own younger sister had the debilitating illness, which causes flu-like symptoms, rashes, joint and muscle pain and limb weakness. With celebrity sufferers including Avril Lavigne and Shania Twain, the disease has increased 25-fold since national surveillance began in 1982, and the common diagnostic test is inaccurate more than half the time.

While Singer is generally private about her sister’s identity and scary health battle, she’s sharing some details of the ordeal for the first time, telling how following the diagnosis, she immediately sprang into action, setting about on a mission to find the best help she could for her loved one.

“She was complaining about all kinds of pain eight years ago, to the point where she was having problems walking,” Singer, 61, shares. “We finally come to our own conclusion that this must be Lyme disease, then she was tested for it. I’ve become a maven since then. I’m aggressive, so I started calling all my friends saying, ‘My sister has Lyme disease, who do you know? Who can I call?’ I was on a rampage to find the best doctor because even once you’re diagnosed, some doctors don’t know how to treat it or can’t be bothered treating it.”

It’s incredible in this day and age how ignorant people are and the tests aren’t always foolproof,” adds Singer, who recalls talking to one sufferer who was experiencing near-psychotic episodes due to the disease reaching his brain, yet kept getting told by doctors he was mentally ill before finally being diagnosed with Lyme disease. “It’s just a really scary disease and it’s not black-and-white.”

Thanks to being detected early, Singer’s sister, now in her fifties, was able to take a 30-day course of antibiotics and make a full recovery, something the family feels eternally “blessed” about. However, several other loved ones have meanwhile been diagnosed with the illness, which is more common in East Coast areas, with one of Singer’s pals still struggling to overcome it.

One of the most gut-wrenching parts of watching those close to her suffer has been seeing how it restricts their ability to live a normal day-to-day life and witnessing the effects the disease can have on a person’s mental health.

“They just have no energy,” says Singer, who has a 23-year-old daughter, Avery. “Life is about having your health — health is everything, and if you’re waking up in the morning and feeling bedridden, you don’t want to go and meet your friends for lunch or work out. Life is about embracing your passions, whether it’s work, family or friends and this disease inhibits people’s lifestyles.”

“It also causes depression,” Singer adds. “When you’re not feeling well or you have a bad cold for a week, you get depressed because you can’t do anything.”

Singer notes how difficult it is for newly diagnosed patients to find resources, the right healthcare specialists and not “feel alone out there,” so she has become an avid supporter of the Global Lyme Alliance, which works towards conquering Lyme disease and other tick-borne disease and helps connect patients with the best doctors.

On Thursday, Singer will attend the organization’s 4th Annual New York Gala at Cipriani 42nd Street, as an honorary speaker for the event, where Younger star Sutton Foster will perform and equestrian Erin Walker (wife of golf champ Jimmy Walker) will serve as the honored guest.

Last year’s gala honored Matchbox Twenty frontman Rob Thomas’ wife, Marisol, who has been battling the disease for 15 years, with Thomas previously telling ET that Lyme disease has been “like a weird alien inhabited my wife.”

Other key supporters of the Global Lyme Alliance include Singer’s fellow Housewives franchise star and Lyme patient, Yolanda Hadid, whom she rubbed shoulders with at last year’s event. “She’s very fortunate as she has lovely children who support her tremendously and I know she has made great strides, but it took a toll on her life, her marriage and on her relationships,” Singer says. “But she has gotten through it and she’s definitely an inspiration.”

Beyond the event, Singer is keeping busy, currently selling the four-bedroom apartment which has been her family home for the last 20 years and preparing to launch her Ageless by Ramona skincare line in the spring.

Then of course there’s another season of RHONY!

With season 11 filming underway, Singer hints she’ll be back for more drama. Season 10’s dramatic finale and reunion show saw her embroiled in further drama with Bethenny Frankel, who refused to support Singer’s business ventures, failing to show up to a pre-launch event for Ageless by Ramona.

“You know, as women, we all have a camaraderie with each other — we fight with passion and we make up with passion, so that’s why the show is still relatable 11 years later,” Singer says about the conflict. “It’s like friendships, right … you have ebbs and flows, highs and lows!”

(Go to link for video.  Approx. 1 Min)
Avril Lavigne is opening up about her battle with Lyme disease.
The 34-year-old singer gets candid about her health, career and more in a new interview for her Billboard cover story, during which she reveals she was in bed for two years amid her Lyme disease battle. The Grammy nominee was on tour in 2014 when she started to feel fatigued and achy, which led her to ask,

“What the f–k is wrong with me?”

When the tour came to an end, one of Lavigne’s friends realized she might have Lyme disease. According to Billboard, she was encouraged to call Canadian music producer David Foster‘s then-wife Yolanda Hadid, who had also been battling Lyme disease. Hadid ended up giving Lavigne the contact information for a Lyme specialist.

Avril Lavigne, Billboard

David Needleman


“I was in bed for f–king two years,” Lavigne tells Billboard. “It’s a bug — a spirochete — so you take these antibiotics, and they start killing it.”

“But it’s a smart bug: It morphs into a cystic form, so you have to take other antibiotics at the same time,” Lavinge continues. “It went undiagnosed for so long that I was kind of f–ked.”

The Billboard interview also states that Lavigne was in bed with her mother one night during her battle, barely able to breathe, when she started to pray.

Avril Lavigne, Billboard

David Needleman


“I had accepted that I was dying,” she tells the outlet. “And I felt in that moment like I was underwater and drowning, and I was trying to come up to gasp for air. And literally under my breath, I was like, ‘God, help me keep my head above the water.'”

That became the inspiration for her song “Head Above Water,” which she released last month after about a five-year hiatus. The singer worked on the song with her ex, Chad Kroeger, who she calls “great” and who also worked on more songs with Lavigne for her upcoming album.

“The silver lining of it is that I’ve really had the time to be able to just be present, instead of being, like, a machine: studio, tour, studio, tour,” she says. “This is the first break I’ve ever taken since I was 15.”

To read more from Lavigne’s interview, pick up a copy of Billboard, on newsstands Friday.

Yolanda Hadid Reveals She’s ‘Not Feeling Good’ Again After ‘One Year of Remission’ From Lyme Disease

The fight continues. Yolanda Hadid revealed during her speech at the Global Lyme Alliance Gala in New York City on Thursday, October 11, that she is struggling with her Lyme disease battle again after one year of remission.
lyme disease
Yolanda Hadid speaks onstage during the Global Lyme Alliance Fourth Annual New York City Gala. Dave Kotinsky/Getty Images

“What keeps me getting up every morning is my two children that also have had Lyme disease,” the 54-year-old began, referring to her model daughter Bella Hadid and son Anwar Hadid. (She is also mother of model Gigi Hadid). “Quite often, I just went to get on with my life and pretend the whole nightmare never happened. I got sick in 2000. We’re now in 2018. I had one year of remission.”

The Real Housewives of Beverly Hills alum then explained she is not quite “back where [she] started” with her illness, but she is also no longer “feeling good.”

“[I’m] just wanting to crawl in a hole and wait for it all to pass, but I also understand the higher purpose of my journey is to continue to bring awareness to this awful disease until the change is made,” Yolanda told the crowd, which included fellow Housewives Luann de Lesseps, Dorinda Medley, Sonja Morgan, Tinsley Mortimer and honored guest Ramona Singer

lyme disease
Ramona Singer, Luann de Lesseps, Tinsley Mortimer, Yolanda Hadid, and Dorinda Medley attend the Global Lyme Alliance Fourth Annual New York City Gala. Rob Kim/Getty Images

“What keeps me awake at night is not my journey the journey of my children and so many children in the world that don’t get the proper treatments that they deserve,” she continued. “Living in today’s world is hard enough as a healthy child. It’s time that we all put an end to this. If I die next week, next month, next year — this is the most, the greatest cause I have ever fought for.”

She concluded:

“Even today, I have been in treatment all day. I feel like s—t. I showed up because this has to change.”

Yolanda has been very vocal about her struggles with Lyme disease over the years, documenting her ups and downs on RHOBH for four seasons and telling her story in her 2017 memoir, Believe Me: My Battle with the Invisible Disability of Lyme Disease.




GLA Video on Lyme

Approx. 4.5 Min

This video premiered at the 2018 Global Lyme Alliance New York Gala. Watch GLA leadership and GLA-funded researchers, among others, share insights into the problem of Lyme disease and what GLA is doing to solve it.



Lots of great info here.  Correcting Senator Blumenthal, Lyme is not an epidemic, it’s a literal pandemic.

Also, there are reasons the map showing Lyme isn’t entirely blacked out:  1)  The CDC maps are notoriously faulty 2) We are only talking about Lyme (borrelia) 3) There are many other pathogens involved in this nightmare that need to be factored in as well and recognized by main-stream medicine, surveillance, researchers, and the media.  These pathogens singularly are serious but when coupled with Lyme are deadly.

Throw these maps out!  Historically maps have been used against seriously ill patients for decades.  They have been denied diagnosis and treatment due to a piece of paper.

This tick border thing is a man-made constructed paradigm that has never been accurate, but it’s fit the CDC/NIH/IDSA narrative. (go to page 6 and read about Speilman’s maps which are faulty but have ruled like the Iron Curtain.)  According to independent Canadian tick researcher, John Scott, Ticks and Lyme are NOT propelled by climate change but by migratory birds and other reservoirs who do not refer to maps in their travels!

For more:



Polio-Like Condition May Be On The Rise In U.S. | NBC Nightly News

NBC News

Published on Oct 8, 2018
Health officials are on alert for cases of Acute Flaccid Myelitis, a rare complication linked to a common virus. Symptoms can include sudden limb weakness, drooping eyelids or face, trouble swallowing, and slurred speech.
Within a week, Quentin Hill went from being an active seven-year-old to a hospital bed. Diagnosed with a rare polio-like illness that at least five other kids in Minnesota now also have.
Doctors are telling you this is something we don’t know much about so there’s no known cure.  The connection between vaccination and paralysis has been known since the 40’s and 50’s and was written about in The Lancet by Stephen Mawdsley in an article titled, “Polio Provocation: Solving a Mystery With the Help of History.” Mawdsley states:
“The application of epidemiological surveillance and statistical methods enabled researchers to trace the steady rise in polio incidence along with the expansion of immunization programs for diphtheria, pertussis, and tetanus. A report that emerged from Guy’s and Evelina Hospitals, London, in 1950, found that 17 cases of polio paralysis developed in the limb injected with pertussis or tetanus inoculations. Results published by Australian doctor Bertram McCloskey also showed a strong association between injections and polio paralysis. Meanwhile, in the USA, public health researchers in New York and Pennsylvania reached similar conclusions.Clinical evidence, derived from across three continents, had established a theory that required attention.”
So what happened to this theory that piercing the skin during injection drives the polio virus into deep tissue where it then enters the central nervous system where it ultimately leads to paralysis and even death?
Good question.
The theory was essentially proven in 1998 in an article titled, “Mechanism of Injury-Provoked Poliomyelitis,” in the Journal of Virology. Researchers state:
“Skeletal muscle injury is known to predispose its sufferers to neurological complications of concurrent poliovirus infections. This phenomenon, labeled ‘provocation poliomyelitis,’ continues to cause numerous cases of childhood paralysis due to the administration of unnecessary injections to children in areas where poliovirus is endemic. Recently, it has been reported that intramuscular injections may also increase the likelihood of vaccine-associated paralytic poliomyelitis in recipients of live attenuated poliovirus vaccines. We have studied this important risk factor for paralytic polio in an animal system for poliomyelitis and have determined the pathogenic mechanism linking intramuscular injections and provocation poliomyelitis.Skeletal muscle injury induces retrograde axonal transport of poliovirus and thereby facilitates viral invasion of the central nervous system and the progression of spinal cord damage. The pathogenic mechanism of provocation poliomyelitis may differ from that of polio acquired in the absence of predisposing factors.”
The virus associated with the recent hospitalizations is Enterovirus D68, which is not polio per se, but is very similar and is in the same family of enteroviruses. Doctor Alan S. Cunningham, MD, a retired pediatrician wrote about his fear of the possibility of provocation of a polio-like virus due to vaccination in The BMJ in 2015:
“Since August 2, 2014, our Centers for Disease Control has received reports of 107 cases of ‘acute flaccid myelitis’ (AFM), a polio-like illness in children in 34 states. During the same interval there have been 1153 cases of respiratory illnesses associated with enterovirus D-68 (CIDRAP News 1/16/15. CDC update 1/15/15. Catherine Saint Louis, NY Times 1/13/15). AFM affects motor neurons in spinal cord gray matter, resulting in asymmetrical limb weakness; 34% of patients have cranial nerve motor dysfunction. Median age of patients is 7.6 years/range: 5 months-20 years (MMWR 63: 1243–January 9, 2015). So far only one child has fully recovered. EV-D68 is a suspected cause but, thus far, no viruses have been found in the spinal fluid of patients, and only a minority have had an antecedent illness associated with EV-D68. Case-control studies are planned to look for clues, but presently AFM is a mystery disease of unknown cause. It is taboo to suggest a role for vaccines, but some old-timers remember “provocation poliomyelitis” or “provocation paralysis.” This is paralytic polio following intramuscular injections, typically with vaccines. PP was most convincingly documented by Austin Bradford Hill and J. Knowelden during the 1949 British polio epidemic when the risk of paralytic polio was increased 20-fold among children who had received the DPT injection (BMJ 2:1–July 1, 1950). Similar observations were made by Greenberg and colleagues in New York City; their literature review cited suspected cases as far back as 1921 (Am J Public Health 42:142–Feb.1952). I first became aware of PP 10 years ago while browsing through “Krugman’s Infectious Disease of Children” (page 128 of the 2004 edition). AFM may result from a direct virus attack on the spinal cord, or by an immune attack triggered by a virus, or by something else.If a polio-like virus is circulating in the U.S., the possibility of its provocation by one or more vaccines has to be considered.”
Polio provocation resurfaced in the 80’s when vaccination programs in developing countries increased in tandem with more children becoming paralyzed.

The US government chose to continue vaccinating and stated,
“any possible doubts, whether or not well founded, about the safety of the vaccine cannot be allowed to exist in view of the need to assure that the vaccine will continue to be used to the maximum extent consistent with the nation’s public health objectives.”
This is important information to consider for MSIDS patients, since our immune systems are compromised and viruses often play a role in our illness, we need to consider the very probable connection with provoked viruses by vaccines along with our other tick borne infections.
For more information on vaccines, please read: Written by the Office of Medical and Scientific Justice and substantiating this further: “One factor common to all the troops is that they were given experimental and potentially dangerous drugs and vaccines employed to protect them against Iraqi chemical and biowarfare agents. As early as December 1990, there were warnings about using our servicemen as medical guinea pigs. In an unprecedented legal decision, the FDA allowed the Pentagon to give unapproved drugs and vaccines without requiring consent of the soldiers. Claiming security reasons, the Pentagon also refused to identify the types or the number of drugs and injections they forced the troops to take… Soldiers who rejected the injections were given them forcibly. Physicians who refused to cooperate with the military’s experimental vaccine program were treated harshly.”

FDA Official Uses Revolving Door to Join BioTech Company Developing mRNA Vaccines

FDA Official Uses Revolving Door to Join BioTech Company Developing mRNA Vaccines


U.S. Food and Drug Administration (FDA) official Wellington Sun, MD has been hired by biotechnology company Moderna Therapeutics, Inc. of Cambridge, MA to head its Vaccine Strategy and Regulatory Affairs division. Dr. Sun was director of the Division of Vaccines and Related Product Applications at the FDA’s Center for Biologics Evaluation and Research (CBER) where he worked on infectious disease policy, including efforts to respond to the 2009 H1N1 influenza pandemic and the 2014-2016 Ebola and 2015-2016 Zika virus outbreaks.1 2

“I am excited to work with the team here to identify new development candidates while progressing the portfolio of existing clinical programs,” said Sun.2

Prior to his 10-year career at the FDA in which he facilitated the approvals of 28 new vaccine applications in infectious diseases and over 100 applications for new vaccine indications, Sun worked at the Centers for Disease Control and Prevention (CDC) where he led research on Dengue fever and West Nile virus. Before that, Sun was a clinician and vaccine researcher for 27 years at the U.S. Army Medical Corps.1 2

According to Moderna’s Chief Medical Officer Tal Zaks, MD, to whom Sun will report, Sun is “uniquely qualified to shape” his company’s development strategy.1

Moderna is poised to become a major player on the vaccine development front. Currently focusing on a brand new class of treatments called messenger RNA (mRNA) vaccines and therapeutics, the company is working to develop new vaccines against a wide range of diseases including cancer, influenza, Zika and Chikungunya, among others.1 2

The central molecule of all forms of life involved in almost all aspects of cell biology, mRNA has been used as a method to deliver genetic information, particularly with mRNA based cancer immunotherapies.3 Scientists have been developing synthetic mRNA that is engineered to resemble mature and processed mRNA molecules not only to create new cancer immunotherapies but also to create new infectious disease vaccines.4

Vaccines using mRNA technology differ from traditional vaccines because they act as a “set of instructions that direct the body to fight or prevent disease.” Immunotherapeutic medicines and mRNA messenger vaccines are being designed to “direct the body’s cells to produce intracellular or secreted proteins” by scientists who believe the mRNA mechanism of action can be engineered to prevent or treat infectious diseases, cancer, cardiovascular and rare diseases.2

However, no new technology comes without the potential for unknown risks, especially one that involves genetic engineering. As one group of mRNA vaccine developers pointed out,

“Historically, the prospect of developing mRNA vaccines was uncertain due to concerns of mRNA instability and the feasibility of large-scale manufacturing.”5

The production of pharmaceutical products using the new mRNA technology is responsible for the Moderna’s current $7 billion valuation. The company is also in “strategic relationships” with such pharmaceutical giants as Merck, AstraZeneca and Vertex, as well as agencies under the auspices of the U.S. Department of Defense, the U.S. Department of Health and Human Services (HHS), and the Bill & Melinda Gates Foundation. Moderna recently opened a major manufacturing plant specifically for its mRNA product development programs.1 2


1 Sagonowsky E. Moderna picks up FDA vaccine official Wellington Sun. FiercePharma Sept. 6, 2018.
2 Press Release. Dr. Wellington Sun Joins Moderna as Head, Vaccine Strategy and Regulatory Affairs. Moderna Therapeutics Sept. 5, 2018.
3 Weissman D. mRNA transcript therapy. Exp Rev Vaccines 2015; 14(2): 265-281.
4 Sahm U, Kanko K, Tureci O. mRNA-based therapeutics – developing a new class of drugs. Nature Review Drug Discovery 2014; 13: 759-780.
5 Brito LA, Kommareddy S et al. Chapter Seven – Self-Amplifying mRNA Vaccines. Advances in Genetics 2015; 89: 179-233.



Those entrusted with public health should not be allowed to have conflicts of interest.  This revolving door thing as well as financial kickbacks to doctors for pushing vaccines must stop.  These policies are endangering patients & the collusion is very real.  In this article we learn the U.S. government has a huge conflict of interest, as it profits from the sale of vaccines, and Gardasil in particular.  The U.S. Centers for Disease Control (CDC) is tasked with vaccine safety, and yet it is also the largest purchaser of vaccines, spending over $4 billion annually to purchase vaccines.

Julie Gerberding was in charge of the CDC from 2002 to 2009, which includes the years the FDA approved the Merck Gardasil vaccine.  Soon after she took over the CDC, she reportedly completely overhauled the agency’s organizational structure, and many of the CDC’s senior scientists and leaders either left or announced plans to leave. Some have claimed that almost all of the replacements Julie Gerberding appointed had ties to the vaccine industry.  Gerberding resigned from the CDC on January 20, 2009, and took over as the president of Merck’s Vaccine division, a 5 billion dollar-a-year operation, and the supplier of the largest number of vaccines the CDC recommends.

Gerberding, now the executive vice president of pharmaceutical giant, Merck, sold 38,368 of her shares in Merck stock for $2,340,064.32. She still holds 31,985 shares of the company’s stock, valued at about $2 million.

The National Institute of Health also holds patents on vaccines, such as Gardasil, and earns royalties from the sale of vaccines.  Dr. Eric Suba tried to use the Freedom of Information Act to find out how much money the National Institute of Health (NIH) earned from the sale of Gardasil, but they refused to report the amount of revenue the government earns from this vaccine (although not denying they do earn royalties).  Health insurance documents reveal Blue Cross Blue Shield gives kickbacks to pediatricians who push vaccines to the tune of 40-80 thousand dollars a year per doctor.

Secondly, this post explains the danger of altering human genetics through vaccinations: